Abstract
Chagas disease (CD) is a tropical and potentially fatal infection caused by Trypanosoma cruzi. Although CD was limited to Latin America as a silent disease, CD has become widespread as a result of globalization. Currently, 6–8 million people are infected worldwide, and no effective treatment is available. Here, we identify new effective agents against T. cruzi. In short, 16 aryl polyamines were screened in vitro against different T. cruzi strains, and lead compounds were evaluated in vivo after oral administration in both the acute and chronic infections. The mode of action was also evaluated at the energetic level, and its high activity profile could be ascribed to a mitochondria-dependent bioenergetic collapse and redox stress by inhibition of the Fe-SOD enzyme. We present compound 15 as a potential compound that provides a step forward for the development of new agents to combat CD.
Funder
Ministerio de Economia, Industria y Competitividad
MINECO and FEDER funds
Alfonso Martín Escudero Foundation
Reference63 articles.
1. Chagas disease;Molina;Lancet,2018
2. WHO (2022, October 02). World Health Organization WHO: Chagas Disease (American Trypanosomiasis). Available online: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis).
3. Chagas disease: Current view of an ancient and global chemotherapy challenge;ACS Infect. Dis.,2020
4. Requena-Méndez, A., Aldasoro, E., de Lazzari, E., Sicuri, E., Brown, M., Moore, D.A., Gascon, J., and Muñoz, J. (2015). Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis. PLoS Negl. Trop. Dis., 9.
5. World Health Organization (WHO) (2018, May 30). Chagas Disease (American Trypanosomiasis). Available online: http://www.who.int/mediacentre/factsheets/fs340/en/.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献